Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionHolderness Investments Co
Latest Disclosed Ownership10,720 shares
Latest Disclosed Value $ 1,494,026
Holderness Investments Co reports 0.17% decrease in ownership of GILD / Gilead Sciences, Inc.

On May 12, 2026 - Holderness Investments Co filed a 13F-HR form disclosing ownership of 10,720 shares of Gilead Sciences, Inc. (CH:GILD) valued at $1,494,026 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 10,738 shares of Gilead Sciences, Inc.. This represents a change in shares of -0.17% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F GILEAD SCIENCES COM 375558103 10,720 -18 -0.17 1,494 13.35 0.3000
2026-02-10 2025-12-31 13F GILEAD SCIENCES COM 375558103 10,738 -50 -0.46 1,318 10.11 0.2681
2025-11-12 2025-09-30 13F GILEAD SCIENCES COM 375558103 10,788 130 1.22 1,197 1.35 0.2444
2025-08-12 2025-06-30 13F GILEAD SCIENCES COM 375558103 10,658 151 1.44 1,182 0.34 0.2541
2025-05-13 2025-03-31 13F GILEAD SCIENCES COM 375558103 10,507 0 0.00 1,177 21.34 0.2745
2025-02-11 2024-12-31 13F GILEAD SCIENCES COM 375558103 10,507 -339 -3.13 971 6.71 0.2140
2024-11-12 2024-09-30 13F GILEAD SCIENCES COM 375558103 10,846 -128 -1.17 909 20.88 0.1985
2024-08-13 2024-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 10,974 -364 -3.21 753 -9.40 0.1776
2024-08-13 2024-06-30 13F GILEAD SCIENCES COM 375558103 10,974 -364 753 0.1776
2024-05-13 2024-03-31 13F GILEAD SCIENCES COM 375558103 11,338 -32 -0.28 831 -9.88 0.2030
2024-02-13 2023-12-31 13F GILEAD SCIENCES COM 375558103 11,370 -125 -1.09 921 6.97 0.2529
2023-11-15 2023-09-30 13F GILEAD SCIENCES COM 375558103 11,495 3 0.03 861 -2.71 0.3352
2023-08-15 2023-06-30 13F GILEAD SCIENCES COM 375558103 11,492 190 1.68 886 -5.55 0.3272
2023-05-12 2023-03-31 13F GILEAD SCIENCES COM 375558103 11,302 178 1.60 938 -1.88 0.3748
2023-02-13 2022-12-31 13F GILEAD SCIENCES COM 375558103 11,124 56 0.51 955 39.82 0.4117
2022-11-14 2022-09-30 13F GILEAD SCIENCES COM 375558103 11,068 574 5.47 683 5.24 0.3104
2022-08-15 2022-06-30 13F GILEAD SCIENCES COM 375558103 10,494 -766 -6.80 649 -2.99 0.2709
2022-05-12 2022-03-31 13F GILEAD SCIENCES COM 375558103 11,260 623 5.86 669 -13.34 0.2230
2022-02-09 2021-12-31 13F GILEAD SCIENCES COM 375558103 10,637 736 7.43 772 11.56 0.2280
2021-11-12 2021-09-30 13F GILEAD SCIENCES COM 375558103 9,901 137 1.40 692 2.98 0.2284
2021-08-09 2021-06-30 13F GILEAD SCIENCES COM 375558103 9,764 678 7.46 672 14.48 0.2219
2021-05-11 2021-03-31 13F GILEAD SCIENCES COM 375558103 9,086 -289 -3.08 587 7.51 0.2108
2021-02-05 2020-12-31 13F GILEAD SCIENCES COM 375558103 9,375 2,798 42.54 546 31.25 0.2118
2020-11-09 2020-09-30 13F GILEAD SCIENCES COM 375558103 6,577 278 4.41 416 -14.23 0.1716
2020-08-13 2020-06-30 13F GILEAD SCIENCES COM 375558103 6,299 2,619 71.17 485 76.36 0.2159
2020-05-13 2020-03-31 13F GILEAD SCIENCES COM 375558103 3,680 3,680 275 0.1554
2019-11-01 2019-09-30 13F GILEAD SCIENCES COM 375558103 0 -3,257 -100.00 0 -100.00
2019-08-02 2019-06-30 13F GILEAD SCIENCES COM 375558103 3,257 -140 -4.12 220 -0.45 0.0998
2019-05-20 2019-03-31 13F GILEAD SCIENCES COM 375558103 3,397 -31 -0.90 221 3.27 0.1058
2019-02-13 2018-12-31 13F GILEAD SCIENCES COM 375558103 3,428 -654 -16.02 214 -32.06 0.1170
2018-11-13 2018-09-30 13F GILEAD SCIENCES COM 375558103 4,082 -350 -7.90 315 0.32 0.1419
2018-08-16 2018-06-30 13F GILEAD SCIENCES COM 375558103 4,432 -100 -2.21 314 -8.19 0.1527
2018-05-10 2018-03-31 13F GILEAD SCIENCES COM 375558103 4,532 631 16.18 342 22.58 0.1689
2018-02-13 2017-12-31 13F GILEAD SCIENCES COM 375558103 3,901 -31 -0.79 279 -12.54 0.1370
2017-11-09 2017-09-30 13F GILEAD SCIENCES COM 375558103 3,932 -500 -11.28 319 1.59 0.1658
2017-08-14 2017-06-30 13F GILEAD SCIENCES COM 375558103 4,432 426 10.63 314 15.44 0.1665
2017-05-08 2017-03-31 13F GILEAD SCIENCES COM 375558103 4,006 4,006 272 0.1381
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.